Cefuroxime and Keratitis - a phase IV clinical study of FDA data

Summary:

Keratitis is reported as a side effect among people who take Cefuroxime (cefuroxime sodium), especially for people who are female, 10-19 old, also take Lotemax, and have Keratitis fungal.

The phase IV clinical study analyzes which people have Keratitis when taking Cefuroxime. It is created by eHealthMe based on reports of 12,808 people who have side effects when taking Cefuroxime from the FDA, and is updated regularly.

What is Cefuroxime?

Cefuroxime has active ingredients of cefuroxime sodium. It is often used in sinusitis. eHealthMe is studying from 12,999 Cefuroxime users. Check the latest studies of Cefuroxime.

What is Keratitis?

Keratitis (eye's cornea, the front part of the eye, becomes inflamed) is found to be associated with 412 drugs and 839 conditions by eHealthMe. Check the latest studies of Keratitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

12,808 people reported to have side effects when taking Cefuroxime.
Among them, 12 people (0.09%) have Keratitis.

Among these 12 people:

What is the gender of people who have Keratitis when taking Cefuroxime? *

female: 91.67 %
male: 8.33 %

What is the age of people who have Keratitis when taking Cefuroxime? *

What are other drugs people take besides Cefuroxime? *

What are other side effects people have besides Keratitis? *

Disease Progression: 7 people, 58.33%
Drug Ineffective: 6 people, 50.00%
Transplant Rejection (a transplant material is not worked): 4 people, 33.33%
Eye Pruritus (eye itching): 4 people, 33.33%
Keratitis Fungal (inflammation of the cornea due to fungal organism): 4 people, 33.33%
Corneal Oedema (corneal swelling): 4 people, 33.33%
Dacryocanaliculitis (1. inflammation of the lacrimal ducts. 2. inflammation of the lacrimal sac and lacrimal canaliculi): 4 people, 33.33%
Drug Resistance (reduction in effectiveness of a drug): 4 people, 33.33%
Eye Abscess: 4 people, 33.33%
Generalised Oedema (swelling all over the body): 1 person, 8.33%

What are the existing conditions these people have? *

Keratitis Fungal (inflammation of the cornea due to fungal organism): 4 people, 33.33%
High Blood Pressure: 1 person, 8.33%
Gastric Ulcer (stomach ulcer): 1 person, 8.33%
Escherichia Urinary Tract Infection (urinary tract infection by escherichia coli): 1 person, 8.33%
Erythema Multiforme (a type of hypersensitivity reaction): 1 person, 8.33%
Chronic Kidney Disease: 1 person, 8.33%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Cefuroxime and have Keratitis?

- Check whether Keratitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cefuroxime:

Cefuroxime (12,999 reports)

Keratitis treatments and more:

Keratitis (4,120 reports)

Browse all side effects of Cefuroxime:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Keratitis:

Keratitis (412 drugs)

Browse all the conditions that are associated with Keratitis:

Keratitis (839 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cefuroxime sodium (the active ingredients of Cefuroxime) and Cefuroxime (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.